KaliVir Immunotherapeutics
Sampath Padmavathi has worked in the field of research for over two decades. Sampath began their career in 1996 as a Research Associate at CLRI. In 2001, they joined the University of Pittsburgh as a Research Associate and later became a Research Instructor in 2017. That same year, they moved to Western Oncolytics as a Scientist and was promoted to Senior Scientist in 2019. In 2020, they joined KaliVir Immunotherapeutics as a Senior Scientist.
Sampath Padmavathi is currently enrolled at the University of Pittsburgh.
KaliVir Immunotherapeutics
KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment that engages a virus’ natural ability to replicate in and kill cancer cells